PE(P-36:4)
|
Basic information |
| Metabolite name | PE(P-36:4) |
 | N/A |
 |
C00350 |
 |
N/A |
| Synonyms | PE36p:4 |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | PE(P-36:4) |
| N/A |
|
C00350 |
|
N/A |
| Synonyms | PE36p:4 |
| No. of studies | 3 |
|
Relationship between PE(P-36:4) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Down |
| Study M122 | Type3 | paroxetine group vs. control group | Prefrontal cortex | BALB/c mouse | Down |
| Study M122 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Down |
| Study M123 | Type3 | rTMS group vs. control group | Prefrontal cortex | Wistar rat | Down |